SISCAPA Assay Technologies logo — SISCAPA® Assay Technologies (SAT) – the smart shortcut to se...

SISCAPA Assay Technologies

SISCAPA® Assay Technologies (SAT) – the smart shortcut to sensitive quantitation of protein biomarkers and targets.

Founded 2011 United States United States 8 employees

General Information

Company Name SISCAPA Assay Technologies
Founded Year 2011
Location United States United States +1
Employees 8
Social

Get notified when SISCAPA Assay Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SISCAPA Assay Technologies

SISCAPA technology is the smart shortcut to sensitive quantitation of protein biomarkers and targets. SISCAPA assays combine the precision of MRM mass spectrometry with the power of affinity enrichment to deliver a superior alternative to conventional immunoassays for protein quantitation. The SISCAPA workflow is highly automated and exploits familiar LC-MS/MS platforms widely used for drug and metabolite quantitation. At SAT we believe quantitation of proteins in biologic samples provides an actionable measure of the state of health, disease and treatment. We provide services and products for sequence-specific protein quantitation and robust generation of data in an automated, multiplexed and high throughput manner. Analysis is carried out using a generic workflow, allowing for validation and industrialization of processes for such applications as biomarker validation, protein bioanalysis, pathway research for therapeutic development and monitoring and for use in laboratory-developed tests. SISCAPA assays enable multiplexed quantitation of proteins over many orders of magnitude dynamic range. The generic, automated workflow ensures robust results with high throughput and precision. SISCAPA services include complete Assay Reagent Development or specialized Assay Implementation to maximize your up-time and help you quantitate proteins with unmatched precision. Our pipeline has generated reagents for SISCAPA quantitation of more than 250 different proteins to date, providing an unparalleled experience base.

No funding data available for SISCAPA Assay Technologies yet.

Get notified when SISCAPA Assay Technologies raises funding

SISCAPA Assay Technologies Alternatives & Competitors

SISCAPA Assay Technologies vs

High-throughput assays for antibody titer, glycosylation and aggregation screening made in Germany

9 employees
Biotechnology, Health Care
SISCAPA Assay Technologies vs

People you trust

11 employees
SISCAPA Assay Technologies vs

Life Discovered. Life Diagnosed.

206 employees
Biotechnology, Manufacturing

FAQ About SISCAPA Assay Technologies

SISCAPA® Assay Technologies (SAT) – the smart shortcut to sensitive quantitation of protein biomarkers and targets.
SISCAPA Assay Technologies was founded in 2011.
SISCAPA Assay Technologies is headquartered in United States.
SISCAPA Assay Technologies has approximately 8 employees.
Top alternatives and competitors to SISCAPA Assay Technologies include PAIA Biotech GmbH, NEOMED-LABS, Meridian Life Science, Inc., ImmunoChemistry Technologies, LLC, Peak Proteins – a Sygnature Discovery Business. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SISCAPA Assay Technologies and PAIA Biotech GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SISCAPA Assay Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy